Skip to main content
Top
Published in: Rheumatology International 12/2009

01-10-2009 | Case Report

Massive lower gastrointestinal haemorrhage, successfully treated with corticosteroids, as main symptom of Schönlein-Henoch purpura

Authors: F. Álvarez-Caro, J. A. Concha-Torre, I. García-Hernández, S. Menéndez-Cuervo, M. los Arcos-Solas, J. Santos-Juanes, E. Ramos-Polo

Published in: Rheumatology International | Issue 12/2009

Login to get access

Abstract

Schönlein-Henoch purpura is a small vessel disease that affects mainly skin and kidney, although several gastrointestinal symptoms may occur including abdominal pain, intussusception, perforation or bleeding. Massive lower gastrointestinal haemorrhage is rare and even more as the main symptom of the disease. We present a case of a 2-year-old boy with Schönlein-Henoch purpura who developed a massive lower gastrointestinal bleeding requiring blood transfusion. In this patient both Schönlein-Henoch purpura and gastrointestinal haemorrhage were successfully treated with intravenous methylprednisolone, avoiding surgical intervention. Physicians need to have a high index of suspicion when evaluating these patients, even more when dermatologic signs are scarce. Glucocorticosteroid therapy may be effective when treating severe gastrointestinal symptoms.
Literature
2.
go back to reference Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, García Fuentes M, Gonzalez-Gay MA (1997) Henoch–Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40:859–864. doi:10.1002/art.1780400513 PubMedCrossRef Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, García Fuentes M, Gonzalez-Gay MA (1997) Henoch–Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40:859–864. doi:10.​1002/​art.​1780400513 PubMedCrossRef
3.
go back to reference Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT, Chiang BL (2005) A nationwide survey on epidemiological characteristics of childhood Henoch–Schonlein purpura in Taiwan. Rheumatology (Oxford) 44:618–622. doi:10.1093/rheumatology/keh544 CrossRef Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT, Chiang BL (2005) A nationwide survey on epidemiological characteristics of childhood Henoch–Schonlein purpura in Taiwan. Rheumatology (Oxford) 44:618–622. doi:10.​1093/​rheumatology/​keh544 CrossRef
4.
go back to reference Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, De Martino M (2005) Henoch–Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 35:143–153. doi:10.1016/j.semarthrit.2005.08.007 PubMedCrossRef Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, De Martino M (2005) Henoch–Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 35:143–153. doi:10.​1016/​j.​semarthrit.​2005.​08.​007 PubMedCrossRef
5.
go back to reference Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch–Schonlein purpura. Arthritis Rheum 33:1114–1121. doi:10.1002/art.1780330521 PubMedCrossRef Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch–Schonlein purpura. Arthritis Rheum 33:1114–1121. doi:10.​1002/​art.​1780330521 PubMedCrossRef
7.
go back to reference Calviño MC, Llorca J, García-Porrúa C, Fernández-Iglesias JL, Rodriguez-Ledo P, González-Gay MA (2001) Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore) 80(5):279–290. doi:10.1097/00005792-200109000-00001 CrossRef Calviño MC, Llorca J, García-Porrúa C, Fernández-Iglesias JL, Rodriguez-Ledo P, González-Gay MA (2001) Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore) 80(5):279–290. doi:10.​1097/​00005792-200109000-00001 CrossRef
12.
go back to reference Caksen H, Odabas D, Kosem M, Arslan S, Oner AF, Atas B et al (2002) Report of eight infants with acute infantile hemorrhagic edema and review of the literature. J Dermatol 29:290–295PubMed Caksen H, Odabas D, Kosem M, Arslan S, Oner AF, Atas B et al (2002) Report of eight infants with acute infantile hemorrhagic edema and review of the literature. J Dermatol 29:290–295PubMed
13.
go back to reference Calabrese LH, Michel BA, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33:1108–1113PubMed Calabrese LH, Michel BA, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33:1108–1113PubMed
14.
go back to reference Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–Scönlein purpura: a randomized, double blind, placebo controlled trial. J Pediatr 149(2):241–247. doi:10.1016/j.jpeds.2006.03.024 PubMedCrossRef Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–Scönlein purpura: a randomized, double blind, placebo controlled trial. J Pediatr 149(2):241–247. doi:10.​1016/​j.​jpeds.​2006.​03.​024 PubMedCrossRef
15.
go back to reference Lawee D (2008) Atypical clinical course of Henoch–Schonlein purpura. Can Fam Physician 54(8):1117–1120PubMed Lawee D (2008) Atypical clinical course of Henoch–Schonlein purpura. Can Fam Physician 54(8):1117–1120PubMed
17.
20.
go back to reference Rech J, Fuchs F, Kallert S, Hueber AJ, Requadt C, Manger B, Kalden JR, Amann K, Strauss R, Schulze-Koops H (2007) Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schönlein purpura with disseminated organ involvement. Clin Rheumatol 26(1):112–114. doi:10.1007/s10067-005-0113-1 PubMedCrossRef Rech J, Fuchs F, Kallert S, Hueber AJ, Requadt C, Manger B, Kalden JR, Amann K, Strauss R, Schulze-Koops H (2007) Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schönlein purpura with disseminated organ involvement. Clin Rheumatol 26(1):112–114. doi:10.​1007/​s10067-005-0113-1 PubMedCrossRef
21.
go back to reference Lamireau T, Rebouissoux L, Hehunstre J-P (2001) Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch-Schönlein purpura. Acta Paediatr 90:1081–1082PubMed Lamireau T, Rebouissoux L, Hehunstre J-P (2001) Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch-Schönlein purpura. Acta Paediatr 90:1081–1082PubMed
Metadata
Title
Massive lower gastrointestinal haemorrhage, successfully treated with corticosteroids, as main symptom of Schönlein-Henoch purpura
Authors
F. Álvarez-Caro
J. A. Concha-Torre
I. García-Hernández
S. Menéndez-Cuervo
M. los Arcos-Solas
J. Santos-Juanes
E. Ramos-Polo
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-0853-3

Other articles of this Issue 12/2009

Rheumatology International 12/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.